Chipiron’s Plan: Better MRI Access, Not Just New Machines
▼ Summary
– Medical device funding has reached its highest level since 2021, with significant investment in diagnostics and imaging companies.
– A major unsolved problem is that critical hardware like MRI machines remains extremely expensive and confined to large hospitals.
– The central challenge is making these costly, hospital-bound technologies accessible in any location.
– Evan Kervella, founder and CEO of Paris-based startup Chipiron, discussed this issue on the TechCrunch podcast Equity.
– Equity is a TechCrunch podcast that releases episodes twice a week and is available on multiple platforms.
Investment in medical devices is surging to heights not witnessed since 2021, with billions flowing into diagnostics and imaging firms. Yet despite this wave of innovation, a stubborn challenge remains unaddressed. Highly advanced equipment like MRI scanners still carries a multi-million dollar price tag, effectively restricting its use to major medical centers. This reality creates a significant gap in healthcare accessibility, leaving many communities without vital diagnostic services. The central question becomes how to liberate such costly, institution-bound technology and deploy it wherever it is needed.
Evan Kervella, the founder and CEO of the Parisian startup Chipiron, recently discussed this very issue on the TechCrunch podcast Equity. He outlined both the scale of the problem and his company’s unique approach to solving it. Rather than focusing solely on building new machines, Chipiron is developing a strategy to dramatically improve how existing MRI capacity is utilized and accessed.
The Equity podcast, a flagship production from TechCrunch, is hosted by Theresa Loconsolo and releases new episodes each Wednesday and Friday. Listeners can find the show on popular platforms including Apple Podcasts, Overcast, and Spotify. For updates and discussions, the podcast maintains a presence on X and Threads under the handle @EquityPod.
(Source: TechCrunch)
